Company Overview and News

172
Trump's New Tariffs Could Hit U.S. Shoppers Where It Hurts - Bloomberg

6h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
UA LNVGF NKE UAA AAPL LNVGY NYTAB HPQ 0992

18
HP Advances in 3D Printing With Production Center in China

15h zacks
HP Inc. (HPQ - Free Report) recently announced that it is launching a production-graded 3D printing center in China in collaboration with Guangdong (Dali) 3D Printing Collaborative Innovation Platform. Notably, this is HP’s largest production-grade 3D printing facility in the Asia Pacific. Powered by Guangdong Lanwan Intelligence Technology, this HP Multi Jet Fusion Technology Mass Manufacturing Center is equipped with 10 printing systems to address the surge in demand for production related parts and prototypes, maintaining the quality and speed of production.
JBL SSYS HPQ

71
HP Inc.: Buy For Total Return And Gain From Share Buybacks

15h seekingalpha
HP Inc. just announced a $4 Billion share buyback with $1.2 Billion still available in the present program.
DLR.PRH HD DLR.PRG DLR.PRJ DLR.PRI ADP ADPVV JNJ DLR EOS HPQ DLR.PRC DLR.PRF

117
Cramer goes out on a limb in support of chipmaker Micron

2018-06-21 cnbc
When CNBC's Jim Cramer listened to Micron Technology's conference call, he found himself considerably less skeptical about the chipmaker's fate than most of the analysts.
MU HPQ

10
HPQ / HP Inc. 11-K

2018-06-21 sec.gov
Document
HPQ

212
HP to Boost Shareholder Return With New Repurchase Program

2018-06-21 zacks
HP Inc. (HPQ - Free Report) , yesterday, in a filing with the U.S. Securities and Exchange Commission (SEC), announced that its board of directors has approved a new share repurchase authorization of $4 billion. However, management stated that the timing and number of shares to be bought will depend upon prevailing market conditions and other factors. The latest approval is in addition to the company’s existing authorization, wherein approximately $1.
MS.PRI MS.PRK AAPL MS.PRE MS.PRF MSFT MS.PRG MS HPQ MS.PRA HPE

13
HPQ / HP Inc. 8-K (Current Report)

2018-06-20 sec.gov
Document
HPQ

10
HP Inc. Board Declares Dividend

2018-06-19 globenewswire
PALO ALTO, Calif., June 19, 2018 (GLOBE NEWSWIRE) -- The HP Inc. board of directors has declared a cash dividend of $0.1393 per share on the company’s common stock.
HPQ

10
HP Introduces Annual Sustainable Impact Report; Renews Commitment to Planet, People and Community

2018-06-19 globenewswire
PALO ALTO, Calif., June 19, 2018 (GLOBE NEWSWIRE) -- HP Inc. (NYSE:HPQ) today released its 2017 Sustainable Impact Report, documenting annual progress and outlining new efforts to drive lasting improvements to the planet, people and communities where the company operates. HP also announced a nearly 8% increase in diversity hires* as well as continued increase of women in senior positions. See the full report at www.
HPQ

10
Guangdong (Dali) 3D Printing Collaborative Innovation Platform and HP Introduce Production-Grade 3D Printing Center in China

2018-06-18 globenewswire
FOSHAN, China, June 18, 2018 (GLOBE NEWSWIRE) -- HP Inc. together with Guangdong (Dali) 3D Printing Collaborative Innovation Platform unveiled a new production-grade 3D printing center in China, the world’s largest manufacturing market. The Platform is powering its new Lanwan Intelligence – HP Multi Jet Fusion Technology Mass Manufacturing Center with 10 HP Multi Jet Fusion 3D printing systems to meet the growing demand for functional prototypes and production-grade parts.
DSYNV HPQ

87
AMD: A Screaming Buy Or Time For Caution? A Long-Term Bull Makes A Case For Both

2018-06-13 seekingalpha
We explore the traders' short-term view, the hype players' mid-term view vs. investors' point of view.
CSCO NVDA HPQ INTC

10
HPQ / HP Inc. FORM 8-K (Current Report)

2018-06-13 sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
HPQ

10
HP Inc. Names Alex Cho President, Personal Systems Business

2018-06-13 globenewswire
PALO ALTO, Calif., June 13, 2018 (GLOBE NEWSWIRE) -- HP Inc. (NYSE:HPQ) today named Alex Cho as President of its Personal Systems business effective immediately. Cho most recently served as Vice President and General Manager of the company’s Commercial PC business group. As head of the $35 billion Personal Systems business, he will lead a global technology portfolio spanning PCs, displays and accessories, services, software, and immersive computing.
HPQ

12
Talend Named a Leader in New Big Data Fabric Report from Premier Analyst Firm

2018-06-12 globenewswire
REDWOOD CITY, Calif, June 12, 2018 (GLOBE NEWSWIRE) -- Talend (NASDAQ: TLND), a global leader in cloud integration solutions, today announced that Forrester Research recognized the company as a Leader in its newly published report, The Forrester Wave™: Big Data Fabric, Q2 2018. Talend earned the highest scores of any vendor in the report in both the Current Offering and Strategy categories, two of the three high-level categories Forrester evaluated.
FORR HPQ TLND

119
There Is A Lot Going On Underneath The Market - Cramer's Mad Money (6/11/18)

2018-06-12 seekingalpha
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Monday, June 11.
EA SIG SQ KMI.WS RH LLY HPE SIG ATVI EL NKE KMI.PRA KMI TWTR HPQ PLAY KMR UNH CVB KMRFZ

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Silicon Investor Message Boards

This table lists all message boards related to HPQ / HP Inc. on message board site Silicon Investor.

Hewlett-Packard (HPQ) HWP -- Hewlett Packard
CUSIP: 428236103